Results 31 to 40 of about 623,160 (229)

Minimal-Change Disease Secondary to Borrelia burgdorferi Infection

open access: yesCase Reports in Nephrology, 2012
Lyme borreliosis is a chronic illness caused by tick-transmitted spirochete Borrelia burgdorferi. Borreliosis can be extremely threatening if it is not diagnosed and treated in early stages. Kidneys are not typically involved in the disease.
Ewa Kwiatkowska   +3 more
doaj   +1 more source

Efficacy of rituximab in thymoma associated minimal change disease: case report

open access: yesBMC Nephrology, 2021
Background Thymomas have been associated with a broad spectrum of autoimmune diseases. Minimal change disease (MCD) is the most frequent pathological lesion reported. Pathophysiological mechanisms involved in secondary MCD, and linking MCD to thymoma are
Zhour El Ouafi   +6 more
doaj   +1 more source

Clinical significance of IgM deposition in pediatric minimal change disease

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2022
Background Idiopathic nephrotic syndrome (INS) is a common pediatric disease. Minimal change disease (MCD) is the most common histopathological subtype and usually has good prognosis.
Duaa M. Al Romaili   +5 more
doaj   +1 more source

The Treatment of Minimal Change Disease in Adults [PDF]

open access: yesJournal of the American Society of Nephrology, 2013
Minimal change disease (MCD) is the etiology of 10%-25% of cases of nephrotic syndrome in adults. The mainstay of treatment for adult MCD, oral glucocorticoids, is based on two randomized controlled trials and extensive observational data in adults, and this treatment leads to remission in over 80% of cases.
Jonathan, Hogan, Jai, Radhakrishnan
openaire   +2 more sources

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

A Case of Glomerulonephritis Associated with Klinefelter' Syndrome [PDF]

open access: yesKosin Medical Journal, 2012
Klinefelter' syndrome is a disorder of sexual differentiation in males, characterized by the presence of two or more X-chromosomes, hypogonadism, and lack of secondary sexual characteristics.
Jin Hyuk Cho   +5 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease

open access: yesBMC Nephrology, 2021
Background Minimal change disease is a common cause of nephrotic syndrome in adults. Higher relapse rate put patients at risk of steroids toxicity due to long-term exposure.
Diankun Liu   +8 more
doaj   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

Ipilimumab-associated minimal-change disease [PDF]

open access: yesKidney International, 2016
To the Editor: We read with great interest the review of new drug toxicities in the onco-nephrology world. We would like to highlight a case of minimal-change disease and interstitial nephritis related to the use of ipilimumab. This drug has been described as causing acute kidney injury from interstitial nephritis as well as lupus nephritis in the past,
Jason M, Kidd, Andinet B, Gizaw
openaire   +2 more sources

Home - About - Disclaimer - Privacy